• Explore /
  • Poster
  • / Effects of radium-223 dichloride (Ra-223) with docetaxel (D) versus D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial.

Effects of radium-223 dichloride (Ra-223) with docetaxel (D) versus D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial.

Abstract Poster

Authors

Michael Morris

Michael J. Morris

Memorial Sloan Kettering Cancer Center, New York, NY

Michael J. Morris , Celestia S. Higano , Howard I. Scher , Christopher Sweeney , Emmanuel S. Antonarakis , Daniel H. Shevrin , Charles J. Ryan , Yohann Loriot , Karim Fizazi , Neeta Pandit-Taskar , Jose E. Garcia-Vargas , Kari Lyseng , Marianne Bloma , Anne-Kirsti Aksnes , Jorge A. Carrasquillo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT01106352

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 202)

DOI

10.1200/jco.2015.33.7_suppl.202

Abstract #

202

Poster Bd #

J12

Abstract Disclosures

Similar Posters

First Author: Michael J. Morris

First Author: Michael J. Morris

First Author: Esmail M. Al-Ezzi

First Author: Jae Young Joung